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Experimental Section 
All materials and organic solvents were purchased from Sigma-Aldrich Company (UK), Ltd 
and were used as received. 
1) Cocrystal Preparation: 
Caffeine:Dicarboxylic acid CA:DA cocrystals (Table S1) were obtained by solution 
crystallization as described by Trask and Jones1. Slight modifications to their methods were 
required to prepare bulk materials: 
Caffeine:Oxalic acid, CA:OX: anhydrous β-CA (4.87 g; 25.1 mmol) and OX (1.13 g; 12.5 
mmol) were dissolved in 7:2 (v/v) chloroform/methanol (90 mL) using heating reflux, then 
precipitation was performed under vacuum.  
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Caffeine:malonic acid, CA:MO: anhydrous β-CA (4.73 g; 24.4 mmol) and MO (1.27 g; 12.2 
mmol) were dissolved in 30:1 (v/v) chloroform/methanol (50 mL) using heating reflux, then 
precipitation was performed under vacuum.  
Caffeine:glutaric acid form II, CA:GL FII: anhydrous β-CA (3.57 g; 18.4 mmol) and GL 
(2.43 g; 18.4 mmol) were dissolved in chloroform (60 mL) using heating reflux, then 
precipitation was performed under vacuum.  
Caffeine:glutaric acid form I, CA:GL FI: anhydrous β-CA (3.57 g; 18.4 mmol) and GL 
(2.43 g; 18.4 mmol) were dissolved in cyclohexane (90 mL) using heating reflux, then 
precipitation was performed under vacuum.  
Caffeine:maleic, CA:ML (1:1): anhydrous β-CA (3.75 g; 19.3 mmol) and ML (2.25 g; 19.3 
mmol) were dissolved in 4:1 (v/v) chloroform/methanol (50 mL), then precipitation was 
performed under vacuum.  
CA:ML (2:1): anhydrous β-CA (4.62 g; 23.8 mmol) and ML (1.38 g; 11.9 mmol) were 
dissolved in 8:1 (v/v) chloroform/methanol (50 mL), then precipitation was performed by 
adding cyclohexane (1 mL) followed by n-hexane (20 mL), powder was collected after drying 
under vacuum.  
Table S1: Prepared CA cocrystals, polymorphs, and their CCDC reference codes: 
Cocrystal Polymorph CCDC code 
CA:OX 2:1 Monoclinic, P21/c GANXUP 
CA:MO 2:1 Orthorhombic, Fdd2 GANYAW 
CA:GL 1:1 Form II: Triclinic, P1̅. EXUQUJ 
CA:GL 1:1 Form I: Monoclinic, P21/c. EXUQUJ01 
CA:ML 1:1 Form I: Monoclinic, P21/n GANYEA 
CA:ML 2:1 Monoclinic, Pc. GANYIE01 
 
 
2) Mixing Processes: 
a. Aqueous Processing: Slurry formation was performed with an excess of cocrystal and 
a molar equivalent of SRD (2-4 g) in a glass vial containing deionised water (~5 ml). The 
slurry was mixed at ambient conditions using a magnetic stirrer for 24 hours. The 
resulting material was analysed using powder X-ray diffraction. 
b. Mechanical Processing: It was performed by dry grinding. The cocrystal and molar 
equivalent of SRD coformer mixture was ground using a Retsch MM200 ball mill, 
equipped with stainless steel 10-mL grinding jars and two 7-mm stainless steel grinding 
balls per jar. The grinding was performed at a rate of 25 Hz for a period of 90 minutes. 
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3) Thermogravimetric Analysis (TGA): 
TGA was performed using a TGA Q500 from TA instruments. Approximately 2 to 4 mg of the 
sample was heated from 30 to 250 °C with a heat rate of 10 °C/min in an open standard 
titanium pan under nitrogen atmosphere. TGA data was analysed using the TA Universal 
analysis software version 4.5A. 
 
4) Powder X-ray Diffraction (PXRD): 
PXRD analysis was done using a Bruker D8 diffractometer with a Cu Kα radiation source 
with a wavelength of 1.540 Å. The emission filament voltage and amperage were 40 kV and 
40 mA, respectively. A scanning range of 4 to 40° 2θ with a step size of 0.02° was used.  
 
5) Equilibrium solubility determinations: 
The saturation shaking flask method2 was conducted by taking an excess of solid (3 g) to 
deionised water in a glass vial. The vials were shaken using a VWR 12L shaking water bath 
(UK), and the shaking was done for 24 h at 27 ± 1 ºC. pH readings were taken prior and 
after shaking using a Metler Toledo S220 Seven Compact™ pH meter. Samples were 
subjected to filtration and dilution prior to HPLC analysis. PXRD analysis was performed on 
the resulting solid to ensure that no physical transformation occurred during saturation. 
 
6) High performance liquid chromatography (HPLC) analysis: 
HPLC analysis was conducted using a Waters e-2695 separation module integrated with a 
degasser and a photodiode array detector (PDA-2998). The peaks were analysed with 
Empower 3 software. The column used was a Waters, Symmetry Shield™ Column, 5 µm, 
and 4.6 x 100 mm. No guard column was used in this separation method. Analytes were 
detected at a wavelength of 205nm. All the chemicals used were laboratory grade and the 
mobile phase solvents were HPLC grade. All samples were analysed with a flow rate of 1.7 
mL/min with an injection volume of 20 µL. The column and samples were stored at 25 °C 
during the analysis. The mobile phase was composed of 25mM Potassium dihydrogen 
phosphate (pH=3) (solvent A) and methanol (solvent B) at a ratio of 88:12 A:B. 
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7) Density functional theory method:  
The GRACE software package version 1.5.43 was used to perform quantum mechanical 
DFT calculations of the lattice energies of CA, its cocrystals and the corresponding 
coformers using the VASP program4 with a correction of the dispersive interaction5 (the DFT-
D method). The starting geometry for each crystal was taken from the Cambridge Structural 
Database (CSD), Table S1. The DFT-D calculated lattice energies after geometry 
optimization were used to estimate the relative stability of a cocrystal in the presence of an 
additive.  
 
8) Gibbs free energy change equation derivation: 
This equation is used to calculate the Gibbs free energy change due to the solid state 
coformer replacement reaction (Reaction 1): 
XaYb + cZ ⇌ XaZc + bY (1) 
Considering the equilibrium solution reaction for each component of reaction (1) which are 
XaYb, cZ, XaZc, and bY, and considering that the thermodynamic activity of the solid is 
equal to one, solution equilibrium reactions and related ∆G° equations are: 
For XaYb: 
XaYb(solid) ⇌ aX(solution) + bY(solution) (2) 
∆GXY
° = −RT ln aX
a aY
b = −RT ln Ksp
XY (3) 
For Z: 
Z(solid)  ⇌ Z(solution)  (4) 
∆GC
° = −RT ln aZ
′  (5) 
For XaZc: 
XaZc(solid) ⇌ aX(solution)  + cZ(solution)  (6) 
∆GXZ
° = −RT ln aX
a aZ
c = −RT ln Ksp
XZ  (7) 
For Y: 
Y(solid) ⇌ Y(solution)  (8) 
∆GY
° = −RT ln aY
′   (9) 
By algebraically combining equilibrium reactions (2, 4, 6, and 8), reaction (1) is obtained. 
Similarly equations (3, 5, 7, and 9) can be combined to form a ∆G° equation (10) for coformer 
replacement (∆GRe
° ). Since thermodynamic activities can be approximated by solubilities, 
pure solubilities of both coformers SC
z  and SB
y
 are used instead of thermodynamic activities.6 
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∆GRe
° = −RT ln
Ksp
XYaZ
c
Ksp
XZaY
b
= −RT ln
Ksp
XYSZ
c
Ksp
XZSY
b
(10) 
 
Where Ksp is the solubility product of a cocrystal and S is the equilibrium solubility for a pure 
component. There are four possible general reactions in case of CA:DA coformer 
replacement with SRD, which depend primarily on the stoichiometry of the cocrystals 
involved: 
Type 1: XY + Z ⇌ XZ+ Y 
Type 2: X2Y + Z ⇌ X2Z  + Y 
Type 3: 2XY + Z ⇌ X2Z  + 2Y 
Type 4: X2Y + Z ⇌ XZ + Y+ X 
 
Equation (3) can be applied for all types, with a slight change in case of type 4 where CA 
solubility (SA) is added: 
∆GRe
° = −RT ln
Ksp
XYSZ
c
Ksp
XZSY
bSX
 (4) 
Solubilities and solubility products of pure components and cocrystals, respectively, were 
determined using the shaking flask method followed by HPLC analysis methods (see 
sections 5 and 6) 
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Supporting Results: 
9) Characterisation of prepared cocrystals by PXRD:  
Cocrystals were successfully prepared with good crystallinity; PXRD patterns are shown 
in Figure S1. 
 
Figure S1: PXRD patterns for: 1) Exp CA:OX, 2) Sim** CA:OX, 3) Exp CA:MO, 4) Sim 
CA:MO, 5) Exp CA:GL FII, 6) Sim CA:GL FII, 7) Exp CA:GL FI, 8) Sim CA:GL FI 9) Exp 
CA:ML 1:1, 10) Sim CA:ML 1:1, 11) Exp CA:ML 2:1, and 12) Sim CA:ML 2:1. Exp = 
Experimental result of solution crystallization method, ** Sim = simulated pattern. 
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10) Aqueous processing reactions: 
 
Figure S2: PXRD patterns for CA:OX 2:1 after aqueous processing in the presence of 
SRDs: 1) experimental CA:OX 2:1, 2) CA:OX 2:1 slurry, 3) CA:OX 2:1 + ML slurry, 4) CA:OX 
2:1 + GL slurry, 5) CA:OX 2:1 + MO slurry, 6) CA:OX 2:1 + OX slurry, and 7) sim CA:OX 2:1. 
This shows how CA:OX 2:1 sustained its structure in the presence of all SRDs after slurrying 
for 24 h. 
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Figure S3. PXRD patterns for CA:MO after aqueous processing in the presence of SRDs: 1) 
experimental CA:MO, 2) CA:MO slurry, 3) CA:MO + ML slurry, 4) CA:MO + GL slurry, 5) 
CA:MO + MO slurry, 6) simulated CA:MO, 7) CA:MO + OX slurry, and 8) simulated CA:OX. 
This shows how CA:MO sustained its structure in the presence of all SRDs after slurrying for 
24 h except OX were the pattern changed to CA:OX. 
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Figure S4. PXRD patterns for CA:GL FI after aqueous processing in the presence of SRDs: 
1) experimental CA:GL FI, 2) simulated CA:GL FI, 3) CA:GL FI slurry, 4) CA:GL FI + ML 
slurry, 5) CA:GL FI + GL slurry, 6) simulated CA:GL FII, 7) CA:GL FI + MO slurry, 8) 
simulated CA:MO, 9) CA:GL FI + OX slurry, and 10) simulated CA:OX. CA:GL FI undergoes 
polymorphic transformation to FII when slurried alone or in the presence of ML or GL. 
Moreover, coformer replacement is observed after slurrying in the presence of MO or OX.  
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Figure S5. PXRD patterns for CA:ML 1:1 after aqueous processing in the presence of 
SRDs: 1) experimental CA:ML 1:1, 2) CA:ML 1:1 slurry, 3) CA:ML 1:1 + ML slurry, 4) 
simulated CA:ML 1:1, 5) CA:ML 1:1 + GL slurry, 6) simulated CA:GL FII, 7) CA:ML 1:1 + MO 
slurry, 8) simulated CA:MO, 9) CA:ML 1:1 + OX slurry, and 10) simulated CA:OX. CA:ML 1:1 
undergoes coformer replacement after slurrying in the presence of GL, MO, or OX. No 
transformation is observed when slurried alone or in the presence of ML.  
 
 
 
4 6 8 10 12 14 16 18 20 22 24 26 28 30 32 34 36 38 40
Irel 
2θ / º 
5) 
2) 
3) 
6) 
4) 
1) 
7) 
8) 
9) 
10) 
12 
 
11) Mechanical processing reactions: 
 
Figure S6: PXRD patterns for CA:ML 2:1 after mechanical processing in the presence of 
SRDs: 1) Exp CA:ML 2:1, 2) sim CA:ML 2:1, 3) CA:ML 2:1 grind, 4) CA:ML 2:1 + ML grind, 
5) sim CA:ML 1:1, 6) CA:ML 2:1 + GL grind, 7) sim CA:GL FII, 8) CA:ML 2:1 + MO grind, 9) 
sim CA:MO, 10) CA:ML 2:1 + OX grind, and 11) sim CA:OX. CA:ML 2:1 undergoes coformer 
replacement by OX, MO, or GL during mechanical processing. Moreover, it is subjected to 
stoichiometric conversion in the presence of additional ML.  
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Figure S7: PXRD patterns for CA:OX after mechanical processing in the presence of SRDs: 
1) Exp CA:OX, 2) CA:OX grind, 3) CA:OX + ML grind, 4) CA:OX + GL grind, 5) CA:OX + MO 
grind, 6) CA:OX + OX grind, and 7) sim CA:OX. CA:OX is resistant to coformer replacement 
by other SRDs during mechanical processing. 
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Figure S8. PXRD patterns for CA:MO after mechanical processing in the presence of SRDs: 
1) experimental CA:MO, 2) CA:MO grind, 3) CA:MO + ML grind, 4) CA:MO + GL grind, 5) 
CA:MO + MO grind, 6) simulated CA:MO, 7) CA:MO + OX grind, and 8) simulated CA:OX. 
Similar to aqueous processing, mechanical processing of CA:MO in the presence of OX has 
caused coformer replacement. Moreover, the presence of other SRDs has not caused any 
change.   
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Figure S9. PXRD patterns for CA:GL FII after mechanical processing in the presence of 
SRDs: 1) experimental CA:GL FII 2) CA:GL FII grind, 3) CA:GL FII + ML grind, 4) CA:GL FII 
+ GL grind, 5) simulated CA:GL FII, 6) CA:GL FII + MO grind, 7) simulated CA:MO,  8) 
CA:GL FII + OX grind, and 9) simulated CA:OX. Both OX or MO can induce coformer 
replacement if present during mechanical processing of CA:GL FII. However, CA:GL FII 
resists replacement and sustains its structure during mechanical processing alone or in the 
presence of ML or GL. 
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Figure S10. PXRD patterns for CA:GL FI after mechanical processing in the presence of 
SRDs: 1) experimental CA:GL FI, 2) simulated CA:GL FI, 3) CA:GL FI grind, 4) CA:GL FI + 
ML grind, 5) CA:GL FI + GL grind, 6) simulated CA:GL FII, 7) CA:GL FI + MO grind, 8) 
simulated CA:GL, 9) CA:GL FI + OX grind, and 10) simulated CA:OX. CA:GL FI exhibits 
polymorphic transformation after mechanical processing alone or in the presence of ML or 
GL as SRDs. In addition, the presence of MO or OX during activation leads to coformer 
replacement. 
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Figure S11. PXRD patterns for CA:ML 1:1 after mechanical processing in the presence of 
SRDs: 1) experimental CA:ML 1:1, 2) CA:ML 1:1 + ML grind, 3) CA:ML 1:1 + GL grind, 4) 
simulated CA:ML 1:1, 5) CA:ML 1:1 + MO grind, 6) simulated CA:MO, 7) CA:ML 1:1 + OX 
grind, and 8) simulated CA:OX. CA:ML 1:1 exhibits no physical transformation after 
mechanical processing alone or in the presence of ML or GL. However, coformer 
replacement is observed in the presence of MO or OX.   
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12) Thermal gravimetric analysis (TGA): 
 
Figure S12: TGA thermogram of CA:OX cocrystal. 
 
Figure S13: TGA thermogram of CA:MO cocrystal. 
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Figure S14: TGA thermogram of CA:GL FII cocrystal. 
 
Figure S15: TGA thermogram of CA:GL FI cocrystal. 
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Figure S16: TGA thermogram of CA:ML 1:1 cocrystal. 
 
 
Figure S17: TGA thermogram of CA:ML 2:1 cocrystal. 
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Figure S18: TGA thermogram of OX. 
 
Figure S19: TGA thermogram of MO. 
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Figure S20: TGA thermogram of GL. 
 
 
Figure S21: TGA thermogram of ML. 
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13) DFT Computational data: 
Lattice energy calculation results are presented in Tables S2, S3 and S4. Lattice energies of the most stable polymorph (Table S3) for each 
molecule were used to calculate the relative stabilities of the cocrystals (Table S4). In the case of caffeine it should be pointed out that we have 
used the optimised lattice energy of its most stable polymorph for the calculation of the stabilities of the co-crystal.  At room temperature, 
caffeine is known to possess some disorder7 but our choice is consistent with our overall approach which ignores temperature effects.  
Table S2: Optimized unit cell parameters and their deviations from experimental determinations. 
CCDC 
Reference 
code 
Crystal 
Optimized Cell Percentage Error[a] 
a/Å b/Å c/Å α/deg β/deg γ/deg a b c α β γ 
NIWFEE038 CA 8.34 8.62 11.39 68.5 78.3 73.5 0.2 -0.6 0.2 -0.6 -0.4 -1.1 
GLURAC069 GL α-form 13.01 6.62 17.02 90.0 98.5 90.0 0.0 0.3 -0.7 0.0 0.6 0.0 
GLURAC0810 GL β-form 4.47 14.63 15.82 90.0 96.4 90.0 1.2 -0.9 -0.6 0.0 -0.1 0.0 
MALIAC1211 ML P21/c 30.42 31.21 4.67 90.0 90.0 90.0 0.1 -0.2 0.0 0.0 0.0 0.0 
MALIAC1311 ML Pc 6.84 12.59 15.82 90.0 94.0 90.0 -0.3 0.7 -0.1 0.0 0.5 0.0 
MALNAC0212 MO β-form 7.77 8.08 12.19 77.7 77.7 70.0 -2.7 0.2 0.3 0.2 0.1 0.1 
MALNAC1013 MO ε-form 13.15 6.91 25.65 90.0 97.7 90.0 -0.4 -0.9 -2.5 0.0 -0.1 0.0 
OXLAC0614 OX α-form 25.44 4.91 9.76 90.0 96.3 90.0 -0.6 -1.8 -4.2 0.0 3.7 0.0 
OXLAC1110 OX β-form 12.97 4.69 9.91 90.0 95.3 90.0 0.5 -2.3 0.6 0.0 -2.0 0.0 
EXUQUJ15 CA:GL 1:1 FII 7.41 10.15 7.54 90.0 124.6 90.0 -0.8 0.6 -0.1 0.0 0.2 0.0 
EXUQUJ0115 CA:GL 1:1 FI 3.74 7.42 8.53 90.0 102.0 90.0 1.2 -0.8 -0.7 0.0 -0.2 0.0 
GANYEA16 CA:ML 1:1 FI 5.18 5.27 8.32 70.9 77.5 82.9 0.5 -1.4 -1.1 -0.8 1.8 -2.6 
GANYEA0117 CA:ML 1:1 FII 4.75 34.37 7.81 90.0 98.4 90.0 -0.7 0.5 2.1 0.0 0.1 0.0 
GANYIE0117 CA:ML 2:1 5.19 5.28 8.27 108.0 97.9 97.1 0.7 -0.9 1.2 0.0 -3.5 1.9 
GANYAW16 CA:MO 2:1 44.05 14.85 6.88 90.0 106.3 90.0 2.3 -1.5 -1.1 0.0 6.8 0.0 
GANXUP16 CA:OX 2:1 6.58 6.09 7.55 90.0 90.0 90.0 0.3 -0.1 -4.0 0.0 0.0 0.0 
[a] Positive values indicate that the optimized cell is larger than the experimental unit cell. 
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Any change in unit cell parameters above 4% is unusual. The largest deviations are for 
CA:MO 2:1 which shows a 6.8% change in the angle of the unit cell, and OX α-form and 
CA:OX 2:1, which show deviations of 4% or more in one of the unit cell parameters. 
Table S3: Lattice energies of the most stable polymorphs. 
Molecule 
Most stable polymorph energy 
Kcal/mol/molecule 
Most stable polymorph 
CA -3653.752 Caffeine 
GL -2413.325 Glutaric acid β-form 
ML -1831.492 Maleic acid P21/c 
MO -1639.372 Malonic β’-form 
OX -1245.356 Oxalic acid β-form 
 
Table S4: Stabilities of the cocrystals[a] 
Cocrystal Energy of Coformers Energy of Cocrystal 
Stability of 
Cocrystal 
CA:OX 2:1 -8552.9 -8562.2 -9.3 
CA:MO 2:1 -8946.9 -8950.4 -3.5 
CA:GL 1:1 FII -6067.1 -6068.4 -1.3 
CA:GL 1:1 FI -6067.1 -6067.5 -0.4 
CA:ML 1:1 -5485.2 -5486.4 -1.2 
CA:ML 2:1 -9139.0 -9139.1 -0.1 
[a] Energies are in kcal/mol of formula unit. The cocrystal is stable when the energy is 
negative.   
 
14) pH measurements: 
For each sample, the pH was determined at point zero (pH0) and after 24 hours (pH24). Slight 
variations were observed for pH values between the saturated solutions of the cocrystals, 
ranging between 1.0 and 2.5, which means that pH had no significant effect on S 
measurements (Table S5).  
Table S5. pH levels at time 0, pH0, and after 24 h, pH24, for each cocrystal and relevant pure 
components: 
Component pH0 pH24 Cocrystal pH0 pH24 
CA 5.5 2.6 CA:OX 2:1 1.6 1.8 
OX 1.3 1.2 CA:MO 2:1 1.9 1.5 
MO 1.3 0.5 CA:GL 1:1 FII 2.1 2.3 
GL 1.4 1.3 CA:GL 1:1 FI - - 
ML 1.2 1.1 CA:ML 1:1 1.6 1.5 
 CA:ML 2:1 - - 
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15) Gibbs free energy change results: 
The change in Gibbs free energy for coformer replacement reactions (∆GRe
° ) was calculated 
from measurements of the solubility products (Ksp), and equilibrium solubilities (S) in water 
for CA cocrystals and their pure components, respectively. 
The changes in internal energy (ΔE) calculated by the DFT-D method in addition to ∆GRe
°  
values calculated from solubilty data for coformer replacement reactions are listed in Table 
S6. 
 
Table S6. Energy changes (kcal/mol) for coformer replacement reactions and cocrystal 
integrity observations whether replacement (Rep) is taking place (√) or not (X) under slurry 
processing. 
Starting 
Cocrystal 
SRD Result ∆𝑬 ∆𝑮𝑬𝒙
°  Rep 
CA:OX[b] 
MO CA:MO 
5.79 7.50 X 
CA:GL FII[c] -0.82 -2.56 √ 
CA:GL FI[c] -2.65 -* √ 
CA:ML 1:1[c] -1.12 -1.03 √ 
CA:ML 2:1[b] -3.38 -* √ 
CA:OX[d] 
GL CA:GL FII 
7.96 11.44 X 
CA:MO[d] 2.17 3.95 X 
CA:GL FI[a] -0.91 -* √ 
CA:ML 1:1[a] -0.15 0.76 √ 
CA:ML 2:1[d] -1.21 -* √ 
CA:OX[d] 
GL CA:GL FI 
8.88 -* X 
CA:MO[d] 3.08 -* X 
CA:GL FII[a] 0.91 -* X 
CA:ML 1:1[a] 0.76 -* N/A 
CA:ML 2:1[d] -0.30 -* N/A 
CA:OX[b] 
ML CA:ML 2:1 
9.18 -* X 
CA:MO[c] 3.38 -* X 
CA:GL FII[c] 2.56 -* X 
CA:GL FI[c] 0.74 -* X 
CA:ML 1:1[b] 2.27 -* X 
[a]: Reaction type 1 (XY + Z ⇌ XZ + Y), [b]: Type 2 (X2Y + Z ⇌ X2Z + Y), [c]: Type 3 (2XY + 
Z ⇌ X2Z + 2Y), [d]: Type 4 (X2Y + Z ⇌ XZ + Y+ X), *: results could not be obtained due to 
experimental difficulties. 
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